NorthStar Medical Radioisotopes appointed Frank Scholz, PhD, as its new senior vice president (VP) and chief operating officer (COO).
Scholz brings more than 20 years of experience to the job and will report to the firm's president and CEO Stephen Merrick. He will focus on production capacity, next-generation technetium-99m generators, and new products such as copper-67, actinium-225, and its SPECT imaging agent FibroScint, according to NorthStar.
Scholz has previously served as managing director at AlixPartners, Mallinckrodt Pharmaceuticals, and McKinsey, NorthStar said.
